Search

Your search keyword '"Zhang, Ti"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Zhang, Ti" Remove constraint Author: "Zhang, Ti" Topic hepatocellular carcinoma Remove constraint Topic: hepatocellular carcinoma
23 results on '"Zhang, Ti"'

Search Results

6. Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study.

8. The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib.

9. Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma.

10. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

11. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma

12. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.

13. Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.

14. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.

15. Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.

16. The Indications for Hepatectomy for Multinodular Hepatocellular Carcinoma: Experience from a Single Institution.

17. Silencing thioredoxin induces liver cancer cell senescence under hypoxia.

18. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells

19. Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathway.

20. Pulmonary metastasis of hepatocellular carcinoma: pathogenesis and therapeutic advances

21. Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma.

22. Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma.

Catalog

Books, media, physical & digital resources